Stefan Gross, Head of Biochemistry at Servier: Driving Innovation in Drug Discovery
Improving the lives of our patients
We work tirelessly to deliver meaningful therapeutics for the patients we serve.
ONCOLOGY & Neurology
Smaller patient populations are not deterrents for Servier, we see each patient as a person who is desperately in need of new therapeutic options
39 Active Servier Oncology and Neurology Programs
24
Pre-Clinical
7
Phase 1
4
Phase 2
3
Phase 3
1
Filing
CAREER
See a future at Servier?
NEWSROOM
Latest Servier News
Servier Ranked Among Top Companies Across Several Categories in 2024 PatientView Corporate Reputation of Pharma Survey
Servier to Acquire Exclusive Worldwide Rights of BioNova’s BN104, a potential best-in-class menin inhibitor